BioNovo, Inc.

Bionovo, Inc. is a pharmaceutical company focused on the discovery and development of drugs for the treatment of unmet medical needs in women’s health and cancer in the United States. The company’s drug development process utilizes botanical sources used in traditional Chinese medicine to produce biologically active compounds. Its lead drug candidate, Menerba, a selective estrogen receptor beta agonist, is a proprietary oral formulation of 18 botanically derived active pharmaceutical ingredients designed to reduce the frequency and severity of menopausal hot flashes. This drug candidate is in Phase III clinical trial for the treatment of hot flashes. The company is also developing Bezielle, an oral anti-cancer agent, which is in two separate Phase I clinical trials for treating advanced breast cancer and pancreatic cancer; and Seala for the treatment of postmenopausal vaginal atrophy and dryness.

*past representation